[X]
|
QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2015
|
OR
|
|
[ ]
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Large Accelerated Filer
|
[ ]
|
Accelerated Filer
|
[ ]
|
|
Non-accelerated Filer (Do not check if smaller reporting company)
|
[ ]
|
Smaller Reporting Company
|
[X]
|
|
Page
|
|
|
||
FINANCIAL STATEMENTS.
|
3
|
|
3
|
||
4
|
||
5
|
||
6
|
||
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS.
|
15
|
|
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.
|
18
|
|
CONTROLS AND PROCEDURES.
|
18
|
|
-
|
||
|
||
|
||
RISK FACTORS.
|
18
|
|
EXHIBITS.
|
19
|
|
20
|
||
21
|
March 31,
2015
(unaudited)
$
|
December 31,
2014
$
|
|||||||
ASSETS
|
||||||||
Current Assets
|
||||||||
Cash
|
–
|
73
|
||||||
Current portion of deferred financing costs
|
515
|
1,020
|
||||||
Total Assets
|
515
|
1,093
|
||||||
LIABILITIES AND STOCKHOLDERS' DEFICIT
|
||||||||
Current Liabilities
|
||||||||
Bank indebtedness
|
5
|
–
|
||||||
Accounts payable and accrued liabilities
|
43,253
|
728,581
|
||||||
Accounts payable and accrued liabilities – related parties
|
20,114
|
304,962
|
||||||
Due to related parties
|
–
|
300,000
|
||||||
Convertible debentures, net of unamortized discount of $21,036 and $36,088,
respectively
|
18,264
|
31,952
|
||||||
Derivative liability
|
56,417
|
70,290
|
||||||
Total Liabilities
|
138,053
|
1,435,785
|
||||||
Stockholders' Deficit
|
||||||||
Preferred Stock
Authorized: 25,000,000 preferred shares, with a par value of $0.001 per share
Issued and outstanding: nil preferred shares
|
–
|
–
|
||||||
Class A Preferred Stock
Authorized: 25,000,000 preferred shares, with a par value of $0.001 per share
Issued and outstanding: 7,500,000 shares
|
7,500
|
7,500
|
||||||
Class B Preferred Stock
Authorized: 15,000,000 preferred shares, with a par value of $0.001 per share
Issued and outstanding: 13,624,300 and nil shares, respectively
|
13,624
|
–
|
||||||
Common Stock
Authorized: 2,000,000,000 common shares, with a par value of $0.001 per share
Issued and outstanding: 1,922,000,000 and 571,564,504 shares, respectively
|
1,922,000
|
571,564
|
||||||
Additional paid-in capital
|
359,592
|
296,785
|
||||||
Accumulated deficit
|
(2,440,254
|
)
|
(2,310,541
|
)
|
||||
Total Stockholders' Deficit
|
(137,538
|
)
|
(1,434,692
|
)
|
||||
Total Liabilities and Stockholders' Deficit
|
515
|
1,093
|
For the Three
Months Ended
March 31,
2015
$
|
For the Three
Months Ended
March 31,
2014
$
|
|||||||
Revenue
|
–
|
–
|
||||||
Operating Expenses
|
||||||||
Consulting fees
|
69,835
|
96,000
|
||||||
General and administrative
|
8,409
|
1,760
|
||||||
Professional fees
|
3,250
|
11,100
|
||||||
Total Operating Expenses
|
81,494
|
108,860
|
||||||
Loss Before Other Expenses
|
(81,494
|
)
|
(108,860
|
)
|
||||
Other Expenses
|
||||||||
Interest expense
|
(22,830
|
)
|
(17,377
|
)
|
||||
Loss on change in fair value of derivative liability
|
(25,389
|
)
|
(44,752
|
)
|
||||
Total Other Expenses
|
(48,219
|
)
|
(62,129
|
)
|
||||
Net Loss
|
(129,713
|
)
|
(170,989
|
)
|
||||
Net Loss Per Share, Basic and Diluted
|
(0.00
|
)
|
(0.00
|
)
|
||||
Weighted Average Shares Outstanding
|
931,678,536
|
377,203,075
|
For the Three
Months Ended
March 31,
2015
$
|
For the Three
Months Ended
March 31,
2014
$
|
|||||||
Operating Activities
|
||||||||
Net loss for the period
|
(129,713
|
)
|
(170,989
|
)
|
||||
Adjustment to reconcile net loss to net cash used in operating activities:
|
||||||||
Accretion of debt discount
|
15,052
|
6,241
|
||||||
Amortization of deferred financing costs
|
505
|
1,537
|
||||||
Loss on change in fair value of derivative liability
|
25,389
|
44,752
|
||||||
Changes in operating assets and liabilities:
|
||||||||
Accounts payable and accrued liabilities
|
50,837
|
68,303
|
||||||
Accounts payable and accrued liabilities – related parties
|
37,857
|
37,397
|
||||||
Net Cash Used in Operating Activities
|
(73
|
)
|
(12,759
|
)
|
||||
Financing activities
|
||||||||
Proceeds from convertible debenture, net of financing costs
|
–
|
15,000
|
||||||
Proceeds from related parties
|
–
|
1,200
|
||||||
Net Cash Provided by Financing Activities
|
–
|
16,200
|
||||||
Change in Cash
|
(73
|
)
|
3,441
|
|||||
Cash, Beginning of Period
|
73
|
3,371
|
||||||
Cash, End of Period
|
–
|
6,812
|
||||||
Non-cash investing and financing activities
|
||||||||
Adjustment to derivative liability due to conversion of debt
|
39,262
|
–
|
||||||
Common stock issued for conversion of debt
|
31,400
|
–
|
||||||
Debt discount due to beneficial conversion feature
|
–
|
15,500
|
||||||
Fair value of common stock issued to acquire license
|
200,000
|
–
|
||||||
Fair value of common stock issued to settle debt
|
1,356,205
|
–
|
||||||
Fair value of Class B preferred stock issued to acquire license
|
13,624
|
–
|
||||||
Supplemental Disclosures
|
||||||||
Interest paid
|
–
|
–
|
||||||
Income tax paid
|
–
|
–
|
g)
|
Derivative Liability
|
h)
|
Basic and Diluted Net Loss Per Share
|
i)
|
Interim Consolidated Financial Statements
|
Balance,
December 31,
2014
$
|
Conversions
$
|
Changes in
Fair Values
$
|
Balance,
March 31,
2015
$
|
|
Derivative Liability
|
70,290
|
(39,262)
|
25,389
|
56,417
|
m)
|
Recent Accounting Pronouncements
|
a)
|
On July 15, 2013, the Company entered into a $27,500 convertible debenture with a non-related party. Under the terms of the debenture, the amount is unsecured, bears interest at 8% per annum, and is due on January 16, 2015. The note is convertible into shares of common stock 180 days after the date of issuance (January 11, 2014) at a conversion rate of 50% of the average of the five lowest closing bid prices of the Company's common stock for the thirty trading days ending one trading day prior to the date the conversion notice is sent by the holder to the Company. As at March 31, 2015, the Company recorded accrued interest of $873 (December 31, 2014 - $3,077), which has been included in accounts payable and accrued liabilities.
In accordance with ASC 470-20, "Debt with Conversion and Other Options", the Company recognized the intrinsic value of the embedded beneficial conversion feature of $27,500 as additional paid-in capital and an equivalent discount which will be charged to operations over the term of the convertible note. During the period ended March 31, 2015, the Company issued 454,000,000 common shares (December 31, 2014 - 23,312,500) for the conversion of $20,040 (December 31, 2014 - $7,460) of this debenture and $2,660 (December 31, 2014 - $nil) of accrued interest. During the period ended March 31, 2015, the Company had amortized $2,260 (December 31, 2014 - $22,461) of the debt discount to interest expense. As at March 31, 2015, the carrying value of the debenture was $nil (December 31, 2014 - $17,780).
On January 11, 2014, the note became convertible resulting in the Company recording a derivative liability of $36,272 with a corresponding adjustment to loss on change in fair value of derivative liabilities. As at March 31, 2015, the Company revalued the derivative liability to its fair value resulting in the Company recording $nil (December 31, 2014 - $23,331) as a gain on change in fair value of derivative liabilities. As at March 31, 2015, the fair value of the derivative liability was $nil (December 31, 2014 - $3,061). Refer to Note 4.
|
b)
|
On October 4, 2013, the Company entered into a $32,500 convertible debenture with a non-related party. Under the terms of the debenture, the amount is unsecured, bears interest at 8% per annum, and is due on July 8, 2015. The note is convertible into shares of common stock 180 days after the date of issuance (April 2, 2014) at a conversion rate of 50% of the average of the five lowest closing bid prices of the Company's common stock for the thirty trading days ending one trading day prior to the date the conversion notice is sent by the holder to the Company. As at March 31, 2015, the Company recorded accrued interest of $3,868 (December 31, 2014 - $3,227), which has been included in accounts payable and accrued liabilities.
In accordance with ASC 470-20, "Debt with Conversion and Other Options", the Company recognized the intrinsic value of the embedded beneficial conversion feature of $32,500 as additional paid-in capital and an equivalent discount which will be charged to operations over the term of the convertible note. During the period ended March 31, 2015, the Company issued 174,000,000 common shares (December 31, 2014 - nil) for the conversion of $8,700 (December 31, 2014 - $nil) of this debenture. During the period ended March 31, 2015, the Company had amortized $10,339 (December 31, 2014 - $10,123) of the debt discount to interest expense. As at March 31, 2015, the carrying value of the debenture was $13,380 (December 31, 2014 - $11,741).
On April 2, 2014, the note became convertible resulting in the Company recording a derivative liability of $47,794 with a corresponding adjustment to loss on change in fair value of derivative liabilities. As at March 31, 2015, the Company revalued the derivative liability to its fair value resulting in the Company recording $18,600 (December 31, 2014 - $2,882 gain) as a loss on change in fair value of derivative liabilities. As at March 31, 2015, the fair value of the derivative liability was $35,615 (December 31, 2014 - $44,912). Refer to Note 4.
|
c)
|
On February 18, 2014, the Company entered into a $15,500 convertible debenture with a non-related party. Under the terms of the debenture, the amount is unsecured, bears interest at 8% per annum, and is due on August 20, 2015. The note is convertible into shares of common stock 180 days after the date of issuance (August 17, 2014) at a conversion rate of 50% of the average of the five lowest closing bid prices of the Company's common stock for the thirty trading days ending one trading day prior to the date the conversion notice is sent by the holder to the Company. As at March 31, 2015, the Company recorded accrued interest of $1,379 (December 31, 2014 - $1,074), which has been included in accounts payable and accrued liabilities.
In accordance with ASC 470-20, "Debt with Conversion and Other Options", the Company recognized the intrinsic value of the embedded beneficial conversion feature of $15,500 as additional paid-in capital and an equivalent discount which will be charged to operations over the term of the convertible note. During the period ended March 31, 2015, the Company had amortized $2,453 (December 31, 2014 - $2,431) of the debt discount to interest expense. As at March 31, 2015, the carrying value of the debenture was $4,884 (December 31, 2014 - $2,431).
|
|
On August 17, 2014, the note became convertible resulting in the Company recording a derivative liability of $21,750 with a corresponding adjustment to loss on change in fair value of derivative liabilities. As at March 31, 2015, the Company revalued the derivative liability to its fair value resulting in the Company recording $6,789 (December 31, 2014 - $1,038 gain) as a loss on change in fair value of derivative liabilities. As at March 31, 2015, the fair value of the derivative liability was $20,802 (December 31, 2014 - $20,712). Refer to Note 4.
|
·
|
The underlying stock price of $0.0001 to $0.0006 was used as the fair value of the common stock as at December 31, 2014.
|
·
|
The underlying stock price of $0.0005 to $0.0011 was used as the fair value of the common stock as at March 31, 2015.
|
·
|
The principal of the debenture on the July 15, 2013 date of issuance was $27,500.
|
·
|
The balance of the principal and interest of the July 15, 2013 debenture on January 11, 2014, the date the debenture became convertible, was $28,579.
|
·
|
The balance of the principal and interest of the July 15, 2013 debenture on December 31, 2014 was $23,117.
|
·
|
The balance of the principal and interest of the July 15, 2013 debenture on March 31, 2015 was $873.
|
·
|
The principal of the debenture on the October 4, 2013 date of issuance was $32,500.
|
·
|
The balance of the principal and interest of the October 4, 2013 debenture on April 2, 2014, the date the debenture became convertible, was $33,782.
|
·
|
The balance of the principal and interest of the October 4, 2013 debenture on December 31, 2014 was $35,727.
|
·
|
The balance of the principal and interest of the October 4, 2013 debenture on March 31, 2015 was $27,668.
|
·
|
The principal of the debenture on the February 18, 2014 date of issuance was $15,500.
|
·
|
The balance of the principal and interest of the February 18, 2014 debenture on August 17, 2014, the date the debenture became convertible, was $16,112.
|
·
|
The balance of the principal and interest of the February 18, 2014 debenture on December 31, 2014 was $16,574.
|
·
|
The balance of the principal and interest of the February 18, 2014 debenture on March 31, 2015 was $16,879.
|
·
|
Capital raising events are not a factor for the debenture.
|
·
|
The debt holder would redeem based on availability of alternative financing 0% of the time increasing 1.0% monthly to a maximum of 10%.
|
·
|
The debt holder would automatically convert the note at maturity if the registration (after 120 days) was effective and the Company is not in default.
|
·
|
The projected annual volatility for each valuation period was based on the historic volatility of the Company of 176% as at December 31, 2013, 175% as at January 11, 2014, 176% as at June 30, 2014, 176% as at August 17, 2014, 170% as at September 30, 2014, 2014, 166% as at October 26, 2014, 168% as at December 2, 2014, 170% as at December 4, 2014, 172% as at December 9, 2014, 183% as at December 31, 2014, 203% as at February 6, 2015, 206% as at February 10, 2015, 209% as at February 13, 2015, 212% as at February 18, 2015, 216% as at February 23, 2015, 222% as at March 2, 2015, 223% as at March 3, 2015, 238% as at March 16, 2015, 240% as at March 17, 2015, 244% as at March 19, 2015, 249% as at March 24, 2015, 251% as at March 25, 2015, and 259% as at March 31, 2015.
|
·
|
An event of default would occur 0% of the time, increasing to 1.0% per month to a maximum of 5%. To date, the debenture is not in default nor converted by the debt holder.
|
|
$
|
|||
Balance, December 31, 2013
|
45,521
|
|||
Derivative loss due to new issuances
|
105,816
|
|||
Adjustment for conversion
|
(59,911
|
)
|
||
Mark to market adjustment
|
(27,136
|
)
|
||
Balance, December 31, 2014
|
70,290
|
|||
Adjustment for conversion
|
(39,262
|
)
|
||
Mark to market adjustment
|
25,389
|
|||
Balance, March 31, 2015
|
56,417
|
a)
|
On March 5, 2015, the Company issued 200,000,000 common shares with a par value of $200,000 pursuant to a license agreement with a third party to acquire the rights to technologies related to emergency management and communications. As the transaction resulted in a change of control, the par value of the license was allocated to additional paid-in capital. As a result of the completion of the transaction, SirenGPS and Paul Rauner are deemed related parties.
|
b)
|
On March 5, 2015, the Company issued 106,050,000 common shares with a fair value of $21,210 for the settlement of accounts payable of $733,500 owing to consultants resulting in a gain on settlement of debt of $712,290. As the transaction was pursuant to the agreement which resulted in a change of control, the gain has been recorded to additional paid-in capital.
|
c)
|
On March 5, 2015, the Company issued 342,150,496 common shares with a fair value of $68,430 for the settlement of $300,000 of principal and $107,479 of accrued interest owing to a company controlled by the former President and CEO of the Company. The transaction resulted in a gain on settlement of debt of $339,049 which was recorded against additional paid-in capital. Refer to Note 7(a).
|
d)
|
On March 5, 2015, the Company issued 74,235,000 common shares with a fair value of $14,847 for the settlement of $215,225 owing to the former President and CEO and companies under his control. The transaction resulted in a gain on settlement of debt of $200,378 which was recorded against additional paid-in capital. Refer to Notes 7 and 8.
|
e)
|
During the period ended March 31, 2015, the Company issued 454,000,000 common shares for the conversion of $20,040 of principal and $2,660 of accrued interest of the July 15, 2013 convertible debenture. As the conversions were within the terms of the agreement, no additional gain or loss was recognized as a result of the conversion.
|
f)
|
During the period ended March 31, 2015, the Company issued 174,000,000 common shares for the conversion of $8,700 of principal of the October 4, 2013 convertible debenture. As the conversions were within the terms of the agreement, no additional gain or loss was recognized as a result of the conversion.
|
a)
|
As at March 31, 2015, the Company owes $570 (December 31, 2014 – $nil) to the President and CEO of the Company for reimbursement of expenses which has been included in accounts payable and accrued liabilities – related parties. The amount owing is unsecured, non-interest bearing, and due on demand.
|
b)
|
As at March 31, 2015, the Company owes $19,544 (December 31, 2014 – $7,518) to the former President and CEO of the Company for reimbursement of expenses which has been included in accounts payable and accrued liabilities – related parties. The amount owing is unsecured, non-interest bearing, and due on demand.
|
c)
|
As at March 31, 2015, the Company owes $nil (December 31, 2014 - $300,000) to a company controlled by former officers and directors of the Company. The amount owing is unsecured, bears interest at 10% per annum, and is due on demand. As at March 31, 2015, the Company has recorded accrued interest of $nil (December 31, 2014 - $102,219) which has been included in accounts payable and accrued liabilities – related parties. During the period ended March 31, 2015, the Company issued 342,150,496 common shares to settle the amounts owing. Refer to Note 5(c).
|
d)
|
As at March 31, 2015, the Company owes $nil (December 31, 2014 - $15,225) to companies under common control by former officers and directors of the Company which has been included in accounts payable and accrued liabilities – related parties. The amounts owing are unsecured, non-interest bearing, and due on demand. During the period ended March 31, 2015, the Company issued 5,251,378 common shares to settle the amounts owing. Refer to Note 5(d).
|
e)
|
During the period ended March 31, 2015, the Company has incurred $20,000 (December 31, 2014 - $120,000) to the former President and CEO of the Company for consulting services. As at March 31, 2015, the Company recorded a related party accounts payable of $nil (December 31, 2014 - $180,000), which has been included in accounts payable and accrued liabilities – related party. The amounts owing are unsecured, non-interest bearing, and due on demand. During the period ended March 31, 2015, the Company issued 68,983,622 common shares to settle the amount owing. Refer to Notes 5(d) and 8(c).
|
a)
|
On October 12, 2011, the Company entered into a verbal consulting agreement with a non-related party whereby the Company will pay a monthly consulting fee for services provided in the amounts of $3,000. The agreement is for a one month term automatically renewing in each successive month unless earlier terminated. On July 18, 2012, the Board of Directors reviewed the consulting agreement and authorized an increase to the monthly consulting fee from $3,000 to $3,750 per month beginning July 2012. On October 1, 2012, the Board of Directors reviewed the consulting agreement and adjusted the consulting fee from $3,750 to $3,000 per month beginning October 2012. On April 8, 2014, The Board of Directors reviewed the consulting agreement and adjusted the consulting fee from $3,000 to $500 per month effective January 1, 2014. On March 5, 2015, the Company entered into a Settlement and Mutual Release Agreement whereby the parties agreed to terminate the consulting agreement and settle all amounts owing under the consulting agreement.
During the period ended March 31, 2015, the Company incurred $1,000 (December 31, 2014 - $6,000) in consulting fees relating to this agreement, of which $nil (December 31, 2014- $48,000) has been recorded in accounts payable and accrued liabilities as at March 31, 2015. During the period ended March 31, 2015, the Company issued 31,815,000 common shares to settle the amount owing of $49,000. Refer to Note 5(b).
|
b)
|
On October 12, 2011, the Company entered into a consulting agreement with a non-related party whereby the Company will pay a monthly consulting fee for services provided in the amounts of $27,500. The agreement is for a one month term automatically renewing in each successive month unless earlier terminated. On April 8, 2014, The Board of Directors reviewed the consulting agreement and adjusted the consulting fee from $27,500 to $21,500 per month effective January 1, 2014. On March 5, 2015, the Company entered into a Settlement and Mutual Release Agreement whereby the parties agreed to terminate the consulting agreement and settle all amounts owing under the consulting agreement.
During the period ended March 31, 2015, the Company incurred $43,000 (December 31, 2014 - $258,000) in consulting fees relating to this agreement, of which $nil (December 31, 2014 - $641,500) has been recorded in accounts payable and accrued liabilities as at March 31, 2015. During the period ended March 31, 2015, the Company issued 74,235,000 common shares to settle the amount owing of $684,500. Refer to Note 5(b).
|
c)
|
On October 12, 2011, the Company entered into a consulting agreement with the former President and CEO of the Company whereby the Company will pay a monthly consulting fee for services provided in the amounts of $3,000. The agreement is for a one month term automatically renewing in each successive month unless earlier terminated. On June 10, 2012, the Board of Directors authorized an increase to the monthly consulting fee from $3,000 to $6,000 per month beginning June 2012. On July 18, 2012, the Board of Directors reviewed the consulting agreement and adjusted the monthly consulting fee to $3,750 beginning July 2012. On April 8, 2014, The Board of Directors reviewed the consulting agreement and adjusted the consulting fee from $3,750 to $10,000 per month effective January 1, 2014. On March 5, 2015, the Company entered into a Settlement and Mutual Release Agreement whereby the parties agreed to terminate the consulting agreement and settle all amounts owing under the consulting agreement.
During the period ended March 31, 2015, the Company incurred $20,000 (December 31, 2014 - $120,000) in consulting fees relating to this agreement, of which $nil (December 31, 2014 - $180,000) has been recorded in accounts payable and accrued liabilities – related parties as at March 31, 2015. During the period ended March 31, 2015, the Company issued 68,983,622 common shares to settle the amount owing of $200,000. Refer to Notes 5(d) and 7(e).
|
d)
|
On January 2, 2013, the Company entered into a consulting agreement with The Holden Group, LLC ("Holden") whereby the Company paid Holden $2,000 and issued 600,000 restricted common shares of the Company upon the execution of the agreement as well as pay $500 on each of the first, second and third month anniversaries of the agreement. These final three payments have been accrued and recorded in accounts payable and accrued liabilities.
|
a)
|
On April 1, 2015, the Company issued a draw-down convertible promissory note to a non-related party in the principal amount of up to $600,000 (The April 1, 2015 Debenture). Under the terms of the promissory note, the amount is unsecured, bears interest at 10% per annum, and is due on April 1, 2016. The note is convertible into shares of common stock at a conversion rate of 50% of the average of the three lowest end-of-day closing prices of the Company's common stock for the twenty-five trading days prior to the date the holder elects to convert all or part of the promissory note.
|
b)
|
On April 1, 2015, the Company consented to the assignment of the February 18, 2014 and the October 4, 2013 convertible debentures. According to the terms of the assignment agreement, the February 18, 2014 note was sold to the purchaser and simultaneously exchanged for a new note (the "New February Note"). In accordance with the exchange, The New February Note was deemed to have been issued February 18, 2014, and carried substantially the same terms as the original note, with the following exceptions: the New February bears 0% interest, and the overall ownership of the purchaser at any one moment shall be limited to 9.99% of the issued and outstanding shares of our common stock. The purchaser also entered into an agreement with original debenture holder, granting the purchaser the exclusive right to acquire the October 4, 2013 note, on or before May 7, 2015.
|
c)
|
On April 2, 2015, the Company entered into an equity line of credit (ELOC) up to $4,000,000 with a non-related party, which allows the Company to "put" shares to the debtor at a 20% discount to the lowest trading price over the five consecutive trading days immediately succeeding the applicable Put Notice Date. The ELOC requires the filing of a registration statement prior to the funds becoming available to the Company. Once the registration is filed, funding under the ELOC occurs at the discretion of the Company. The minimum amount of the Put Notice is restricted to $5,000 and the maximum to 100% of the average of the daily trading dollar volume for the ten consecutive trading days immediately prior to the Put Notice Date but not to exceed an accumulated amount per month of $150,000 unless prior approval is obtained.
|
d)
|
On April 3, 2015, two shareholders of the Company agreed to convert 422,000,000 shares of common stock into 2,215,500 shares of Class B Preferred Stock at the request of the Company, to facilitate the closing of the other transactions herein described.
|
e)
|
On April 6, 2015, the Company entered into a Common Stock Purchase Warrant agreement with a non-related party providing the holder the right to purchase shares of common stock of the Company by investing up to $50,000 into new shares of common stock at a price of $0.001 per share for a period of five years. This warrant agreement was negotiated as part of the draw-down convertible promissory note as described in Note 9(a).
|
f)
|
On April 9, 2015, the Company received $40,000 under the April 1, 2015 Debenture and applied the proceeds to fund operating expenses.
|
g)
|
On April 10, 2015, the Company issued 149,844,444 common shares upon the issuance of $6,743 of principal of the February 18, 2014 convertible debenture. Refer to Note 3(c).
|
h)
|
On April 15, 2015, the Company entered into a draw-down convertible promissory note to a non-related party in the principal amount of up to $100,000 (the April 15, 2015 Debenture). Under the terms of the debenture, the amount is unsecured, bears interest at 10% per annum, and is due on October 15, 2016. The note is convertible into shares of common stock after the maturity date at a conversion rate of 50% of the average of the three lowest closing bid prices of the Company's common stock for the twenty trading days ending on the trading day the conversion notice is received by the Company.
|
i)
|
On April 15, 2015, the Company issued 100,000 warrants to a non-related party. Each warrant entitles the holder to purchase one share of common stock at $0.001 per share until April 15, 2020. The warrants are subject to a cashless conversion feature at the election of the holder.
|
j)
|
On April 16, 2015, the Company received $50,000 under the April 15, 2015 Debenture and applied the proceeds to fund operating expenses.
|
k)
|
On April 22, 2015, the Company received $20,000 under the April 1, 2015 Debenture and applied the proceeds to fund operating expenses.
|
l)
|
On April 23, 2015, the Company issued 164,977,778 common shares for the conversion of $7,424 of principal of the February 18, 2014 convertible debenture. Refer to Note 3(c).
|
m)
|
On May 7, 2015, Under the April 1, 2015 agreement the purchaser exercised the option to purchase the October 4, 2013 debenture on May 7, 2015. According to the terms of the assignment agreement, the October 4, 2013 note was sold to the purchaser and simultaneously exchanged for a new note (the "New October Note"). In accordance with the exchange, The New October Note was deemed to have been issued October 4, 2013, and carried substantially the same terms as the original note, with the following exceptions: the New October Note bears 0% interest, and the overall ownership of the purchaser at any one moment shall be limited to 9.99% of the issued and outstanding shares of our common stock.
|
|
March 31,
2015
$
|
December 31,
2014
$
|
||||||
Current Assets
|
515
|
1,093
|
||||||
Current Liabilities
|
138,053
|
1,435,785
|
||||||
Working Capital Deficit
|
(137,538
|
)
|
(1,434,692
|
)
|
|
March 31,
2015
$
|
March 31,
2014
$
|
||||||
Cash Flows used in Operating Activities
|
(73
|
)
|
(12,759
|
)
|
||||
Cash Flows from Financing Activities
|
–
|
16,200
|
||||||
Net Decrease in Cash During Period
|
(73
|
)
|
3,441
|
Exhibit
|
Incorporated by reference
|
Filed
|
|||
Number
|
Description of Exhibit
|
Form
|
Date
|
Number
|
herewith
|
3.1
|
Articles of Incorporation.
|
S-1
|
3/24/09
|
3.1
|
|
3.2
|
Bylaws.
|
S-1
|
3/24/09
|
3.2
|
|
3.3
|
Amended and Restated Articles of Incorporation.
|
8-K
|
6/14/11
|
3.1a
|
|
3.4
|
Amended and Restated Articles of Incorporation.
|
8-K
|
8/17/11
|
3.1
|
|
10.1
|
Management Agreement between the Company and Mr. Mark Simon dated March 23, 2010.
|
10-K
|
4/07/10
|
10.1
|
|
10.2
|
Promissory Note issued to Newton Management Ltd. dated September 28, 2010.
|
8-K
|
10/08/10
|
10.1
|
|
10.3
|
Amended Management Agreement between the Company and Mr. Mark Simon dated October 1, 2010.
|
8-K
|
11/10/10
|
10.1
|
|
10.4
|
Investors Relations Services Agreement with Blue Chip IR dated October 1, 2010.
|
10-Q
|
11/15/10
|
10.3
|
|
10.5
|
Share Exchange Agreement with AmeriSure Pharmaceuticals LLC dated May 13, 2011.
|
8-K
|
5/16/11
|
10.1
|
|
10.6
|
Promissory Note to Amerisure Pharmaceuticals, LLC dated June 20, 2011.
|
8-K
|
6/29/11
|
10.1
|
|
10.7
|
Promissory Note to Serik Enterprises, Inc.
|
8-K
|
8/12/11
|
10.1
|
|
10.8
|
Settlement Agreement with Vail International Ltd.
|
8-K
|
8/12/11
|
10.2
|
|
10.9
|
Settlement Agreement with Newton Management Ltd.
|
8-K
|
8/12/11
|
10.3
|
|
10.10
|
Settlement Agreement with Mark Simon.
|
8-K
|
8/12/11
|
10.4
|
|
10.11
|
Settlement Agreement with Carrillo Huettel, LLC.
|
8-K
|
8/12/11
|
10.5
|
|
10.12
|
Asset Acquisition Agreement.
|
8-K
|
8/17/11
|
10.1
|
|
10.13
|
Promissory Note with Hillwinds Ocean Energy, LLC.
|
8-K
|
8/17/11
|
10.2
|
|
10.14
|
Settlement Agreement and General Mutual Release with Serik
Enterprises, Inc.
|
10-Q
|
11/21/11
|
10.14
|
|
10.15
|
Draw Down Convertible Promissory Note.
|
10-Q
|
11/21/11
|
10.15
|
|
10.16
|
Intellectual Property License Agreement with Hillwinds Energy
Development Corporation.
|
10-K
|
4/16/12
|
10.1
|
|
10.17
|
Exclusivity and Feasibility Study Agreement with City of Saint
John.
|
8-K
|
12/05/12
|
10.1
|
|
10.18
|
Intellectual Property License Agreement with Hillwinds Energy Development Corporation dated December 10, 2012.
|
8-K
|
12/12/12
|
10.1
|
|
10.19
|
Consulting Agreement with The Holden Group.
|
8-K
|
1/03/13
|
10.1
|
|
10.20
|
Restructuring Agreement with Dennis Holden.
|
8-K/A
|
2/14/13
|
10.1
|
|
10.21
|
Restructuring Agreement with Stephen Walker.
|
8-K/A
|
2/14/13
|
10.2
|
|
10.22
|
Restructuring Agreement with Lance Warren.
|
8-K/A
|
2/14/13
|
10.3
|
|
Exchange Agreement with Denali Equity Group, LLC.
|
10-Q
|
5/20/15
|
10.23
|
X
|
|
14.1
|
Code of Ethics.
|
10-K
|
3/29/11
|
14.1
|
|
21.1
|
List of subsidiaries
|
S-1/A-1
|
1/17/13
|
21.1
|
|
Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
X
|
||||
Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
X
|
||||
99.1
|
Subscription Agreement.
|
S-1/A-1
|
1/17/13
|
99.1
|
|
101.INS
|
XBRL Instance Document.
|
|
|||
101.SCH
|
XBRL Taxonomy Extension – Schema.
|
|
|||
101.CAL
|
XBRL Taxonomy Extension – Calculations.
|
|
|||
101.LAB
|
XBRL Taxonomy Extension – Labels.
|
|
|||
101.PRE
|
XBRL Taxonomy Extension – Presentation.
|
|
|||
101.DEF
|
XBRL Taxonomy Extension – Definition.
|
|
HDS INTERNATIONAL CORP.
|
||
(the "Registrant")
|
||
BY:
|
PAUL RAUNER
|
|
Paul Rauner
|
||
President
|
Exhibit
|
Incorporated by reference
|
Filed
|
|||
Number
|
Description of Exhibit
|
Form
|
Date
|
Number
|
herewith
|
3.1
|
Articles of Incorporation.
|
S-1
|
3/24/09
|
3.1
|
|
3.2
|
Bylaws.
|
S-1
|
3/24/09
|
3.2
|
|
3.3
|
Amended and Restated Articles of Incorporation.
|
8-K
|
6/14/11
|
3.1a
|
|
3.4
|
Amended and Restated Articles of Incorporation.
|
8-K
|
8/17/11
|
3.1
|
|
10.1
|
Management Agreement between the Company and Mr. Mark Simon dated March 23, 2010.
|
10-K
|
4/07/10
|
10.1
|
|
10.2
|
Promissory Note issued to Newton Management Ltd. dated September 28, 2010.
|
8-K
|
10/08/10
|
10.1
|
|
10.3
|
Amended Management Agreement between the Company and Mr. Mark Simon dated October 1, 2010.
|
8-K
|
11/10/10
|
10.1
|
|
10.4
|
Investors Relations Services Agreement with Blue Chip IR dated October 1, 2010.
|
10-Q
|
11/15/10
|
10.3
|
|
10.5
|
Share Exchange Agreement with AmeriSure Pharmaceuticals LLC dated May 13, 2011.
|
8-K
|
5/16/11
|
10.1
|
|
10.6
|
Promissory Note to Amerisure Pharmaceuticals, LLC dated June 20, 2011.
|
8-K
|
6/29/11
|
10.1
|
|
10.7
|
Promissory Note to Serik Enterprises, Inc.
|
8-K
|
8/12/11
|
10.1
|
|
10.8
|
Settlement Agreement with Vail International Ltd.
|
8-K
|
8/12/11
|
10.2
|
|
10.9
|
Settlement Agreement with Newton Management Ltd.
|
8-K
|
8/12/11
|
10.3
|
|
10.10
|
Settlement Agreement with Mark Simon.
|
8-K
|
8/12/11
|
10.4
|
|
10.11
|
Settlement Agreement with Carrillo Huettel, LLC.
|
8-K
|
8/12/11
|
10.5
|
|
10.12
|
Asset Acquisition Agreement.
|
8-K
|
8/17/11
|
10.1
|
|
10.13
|
Promissory Note with Hillwinds Ocean Energy, LLC.
|
8-K
|
8/17/11
|
10.2
|
|
10.14
|
Settlement Agreement and General Mutual Release with Serik
Enterprises, Inc.
|
10-Q
|
11/21/11
|
10.14
|
|
10.15
|
Draw Down Convertible Promissory Note.
|
10-Q
|
11/21/11
|
10.15
|
|
10.16
|
Intellectual Property License Agreement with Hillwinds Energy
Development Corporation.
|
10-K
|
4/16/12
|
10.1
|
|
10.17
|
Exclusivity and Feasibility Study Agreement with City of Saint
John.
|
8-K
|
12/05/12
|
10.1
|
|
10.18
|
Intellectual Property License Agreement with Hillwinds Energy Development Corporation dated December 10, 2012.
|
8-K
|
12/12/12
|
10.1
|
|
10.19
|
Consulting Agreement with The Holden Group.
|
8-K
|
1/03/13
|
10.1
|
|
10.20
|
Restructuring Agreement with Dennis Holden.
|
8-K/A
|
2/14/13
|
10.1
|
|
10.21
|
Restructuring Agreement with Stephen Walker.
|
8-K/A
|
2/14/13
|
10.2
|
|
10.22
|
Restructuring Agreement with Lance Warren.
|
8-K/A
|
2/14/13
|
10.3
|
|
Exchange Agreement with Denali Equity Group, LLC.
|
10-Q
|
5/20/15
|
10.23
|
X
|
|
14.1
|
Code of Ethics.
|
10-K
|
3/29/11
|
14.1
|
|
21.1
|
List of subsidiaries
|
S-1/A-1
|
1/17/13
|
21.1
|
|
Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
X
|
||||
Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
X
|
||||
99.1
|
Subscription Agreement.
|
S-1/A-1
|
1/17/13
|
99.1
|
|
101.INS
|
XBRL Instance Document.
|
|
|||
101.SCH
|
XBRL Taxonomy Extension – Schema.
|
|
|||
101.CAL
|
XBRL Taxonomy Extension – Calculations.
|
|
|||
101.LAB
|
XBRL Taxonomy Extension – Labels.
|
|
|||
101.PRE
|
XBRL Taxonomy Extension – Presentation.
|
|
|||
101.DEF
|
XBRL Taxonomy Extension – Definition.
|
|
(A) | Exchange Note. The Company shall issue to the Holder, and the Holder shall acquire from the Company, that certain Exchange Note dated and issued as of May 5, 2014 in the aggregate original principal amount of $26,400 in exchange for the surrender and cancellation of the Principal and Interest (until October 4, 2014) of the Note Portion. The Exchange Note is being issued in substitution for and not in satisfaction of the Note Portion, provided, however, the Holder acknowledges and agrees that upon the issuance and acceptance of the Exchange Note issued pursuant to this Section the Note Portion will be deemed cancelled and will be promptly surrendered to the Company. The Parties further agree that the "Closing" and the "Closing Date" shall be deemed to occur upon the issuance of the Exchange Note as provided by this Section 1.01 (A) of this Agreement. |
(B) | Delivery of Documents.The Company shall, at the Closing Date, deliver to the Holder duly executed copies of each of the exhibits to this Agreement and faithfully fulfill the obligations set forth in Section 2.08 of this Agreement. |
(i) | the transfer of the Note Portion from the Original Investor to the Holder as contemplated in the Debt Purchase Agreement, an executed copy of which has been furnished to the Company; |
(ii) | the Company hereby waives any requirement for any legal opinion in connection with such transfer, and represents and warrants that no further consent of or action by any other person or entity is required in connection with such transfer. |
(A) | that certain promissory note dated October 4, 2013 (the "Original Note Issuance Date") to Asher Enterprises, Inc. (the "Original Investor") by the Company in the total amount of $32,5000 (the "Original Note"), which was later sold to Jabro Funding Corp (the "Current Investor") is a valid debt and current outstanding obligation of the Company; |
(B) | the Company's receipt before the Original Note Issuance Date of the sum of at least $32,500 from the Original Investor; |
(C) | the Company's Board of Directors duly approved the issuance of the Original Note to the Original Investor and the Exchange Note to Denali Equity Group, LLC. |
(D) | the Company's Board of Directors duly approved the terms of that certain Note Purchase Agreement by and between Jabro Funding Corp. and Denali Equity Group, LLC, dated May 5, 2015. |
(E) | The Company has not received and will not be receiving any new consideration from any persons in connection with the issuance of the Exchange Note and the Company's officers and directors have not entered into or given any commitment contemplating the receipt or acceptance of any said consideration arising out of or relating to the issuance of the Exchange Note. |
(F) | To my best knowledge and after completing the aforementioned review of the Company's shareholder and corporate records, I am able to certify that Jabro Funding Corp. and any affiliate of Jabro Funding Corp. are not officers, directors, or directly or indirectly, 10% or more stockholders of the Company and none of said persons have had any such status in the 120 days immediately preceding the date of this Certificate. |
(G) | To my best knowledge and after completing the aforementioned review of the Company's shareholder and corporate records, I am able to certify that Denali Equity Group, LLC and its partners and management are not officers, directors, or directly or indirectly, 10% or more stockholders of the Company and none of said persons have had any such status in the 120 days immediately preceding the date of this Certificate. |
(H) | The Company represents that it is not a "shell" issuer. If it has previously been a "shell" issuer, the Company represents that at least 12 months have passed since the Company reported Form 10 type information indicating it is no longer a "shell issuer". |
(I) | The Company's Board of Directors have approved duly adopted resolutions approving the Irrevocable Instructions to the Company's Stock Transfer Agent attached as Exhibit D to the Exchange Agreement of May 5, 2015. |
(J) | I understand the constraints imposed under Rule 144 on those persons who are or may be deemed to be "affiliates," as that term is defined in Rule 144(a)(1) of the 1933 Act. |
(K) | I understand that all of the representations set forth in this Certificate will be relied upon by counsel to Denali Equity Group, LLC in connection with the preparation of a legal opinion claiming the exemption provided by Rule 144 of the Securities Act of 1933, as amended. |
1. | I have reviewed this Form 10-Q for the period ended March 31, 2015 of HDS International Corp.; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a. | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b. | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
c. | Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and, |
d. | Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and |
5. | I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): |
a. | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and |
b. | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. |
Date:
|
May 19, 2015
|
PAUL RAUNER
|
Paul Rauner
|
||
Principal Executive Officer and Principal Financial Officer
|
(1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
(2) | The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
PAUL RAUNER
|
|
Paul Rauner
|
|
Chief Executive Officer and Chief Financial Officer
|